Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Perspectives on conversations about costs of cancer care of breast cancer survivors and cancer center staff: A qualitative studyAnnals of Internal Medicine.  170:S54-S61. 2019
2019 Targeted composite value-based endpoints in platinum-sensitive recurrent ovarian cancerGynecologic Oncology.  152:445-451. 2019
2019 Emerging From the Haze: A Pilot Study Evaluating Feasibility of a Psychoeducational Intervention to Improve Cancer-Related Cognitive Impairment in Gynecologic Cancer Survivors.Journal of Palliative Care.  34:32-37. 2019
2018 Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.Gynecologic Oncology.  151:501-505. 2018
2018 Treatment of low-grade endometrial stromal sarcoma in a nulligravid womanGynecologic Oncology.  151:6-9. 2018
2018 Financial toxicity – An overlooked side effectGynecologic Oncology.  150:3-6. 2018
2018 Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare ProvidersJournal of Genetic Counseling.  27:177-186. 2018
2017 ASCO Value Framework Highlights the Relative Value of Treatment Options in Ovarian CancerJournal of Oncology Practice.  13:e1030-e1039. 2017
2015 Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative ComplicationsInternational Journal of Gynecological Cancer.  25:1271-1276. 2015
2015 Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.Gynecologic Oncology.  138:689-693. 2015
2015 Predicting inpatient stay lasting 2 midnights or longer after robotic surgery for endometrial cancer. 2015
2014 Training the next generation of robotic surgeons using guided mentorship: a randomized controlled trial. 2014
2013 Reducing readmissions after robotic surgical management of endometrial cancer: a potential for improved quality care.Gynecologic Oncology.  131:508-511. 2013
2011 Use of a nanoporous biodegradable miniature device to regulate cytokine release for cancer treatmentJournal of Controlled Release.  151:239-245. 2011
2008 Giant breast tumors: surgical management of phyllodes tumors, potential for reconstructive surgery and a review of literature.World Journal of Surgical Oncology.  6:117. 2008
2008 Biphasic anaphylactic reaction to blue dye during sentinel lymph node biopsy.World Journal of Surgical Oncology.  6:79. 2008
2007 Current immunotherapeutic strategies in breast cancer.Surgical Oncology Clinics of North America.  16:841-ix. 2007

Investigator On

  • Private Grant  awarded by Leap Therapeutics, Inc. 2021 - 2026
  • UAB 18107 - A Phase 2, Single Arm Study of Atezolizumab + Bevacizumab in Women with Advanced, Recurrent or Persistent Endometrial Cancer  awarded by University of Oklahoma 2020 - 2025
  • Emotional Well-Being and Economic Burden Research Network  awarded by NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH/NIH/DHHS 2021 - 2025
  • The Role of Multilevel Access Dimensions in Ovarian Cancer Disparities  awarded by Duke University 2019 - 2024
  • Private Grant  awarded by TESARO, INC. 2019 - 2024
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2019 - 2024
  • NRG Oncology Member Institution Clinical Trial Fixed Price Subaward Agreement  awarded by NRG ONCOLOGY FOUNDATION 2019 - 2024
  • Private Grant  awarded by CELSION CORPORATION 2018 - 2023
  • Private Grant  awarded by GENMAB 2018 - 2023
  • Private Grant  awarded by AGENUS, INC. 2020 - 2023
  • Private Grant  awarded by Leap Therapeutics, Inc. 2017 - 2022
  • Private Grant  awarded by ABBVIE INC 2015 - 2021
  • Private Grant  awarded by TESARO, INC. 2016 - 2021
  • UAB 1764:The Targeted Agent and Profiling Utilization Registry (TAPUR) Study  awarded by American Society of Clinical Oncology 2017 - 2021
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2019 - 2021
  • Comprehensive Cancer Center Core Support Grant - Expanding Distress Screening To Optimize Identification Of Cancer Patients Experiencing Financial Hardship To Enhance Delivery Of Financial Navigation Services  awarded by National Cancer Institute/NIH/DHHS 2019 - 2021
  • Therapeutic Use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial  awarded by Hutchinson (Fred) Cancer Research Center 2020 - 2021
  • OB/GYN Faculty Research Career Development Program  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2018 - 2020
  • Private Grant  awarded by TAPIMMUNE, INC. 2018 - 2020
  • Private Grant  awarded by IMMUNOGEN, INC. 2017 - 2019
  • UAB NRG Oncology Master Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2019
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2018 - 2019
  • Education And Training

  • Doctor of Medicine, Ohio State University System : Columbus 2010
  • The Ohio State University, Residency 2014
  • UCLA, Postdoctoral Fellowship 2017
  • Full Name

  • Margaret Liang